Olivet, France

Roland Ollivier


Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • 45160 Olivet, FR (1990)
  • Olivet, FR (1989 - 1991)

Company Filing History:


Years Active: 1989-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Roland Ollivier: A Pioneer in Antihistaminic Derivatives

Introduction

Roland Ollivier, a distinguished inventor based in Olivet, France, has made significant contributions to the field of medicinal chemistry. With a total of three patents to his name, his work focuses on innovative compounds that exhibit promising therapeutic effects.

Latest Patents

Among his latest patents, Ollivier has developed "Benzhydryloxyethylpiperidine derivatives and a process for their preparation." This invention encompasses a range of derivatives characterized by complex formulae, where various substitutions, such as hydrogen, halogen, alkyl, alkoxy, aryloxy groups, or trifluoromethyl groups, can occur. Additionally, he has patented "Benzhydryloxyethylpiperazine derivatives, processes for their preparation." This invention highlights the creation of derivatives that demonstrate antihistaminic activity without corresponding sedative effects, a crucial advancement for patients requiring allergy relief.

Career Highlights

Throughout his career, Ollivier has worked with notable institutions such as Les Laboratoires Meram, where he honed his expertise in pharmaceutical development. His impactful research has positioned him as an influential figure in the pharmaceutical industry, particularly in the realm of antihistaminic compounds.

Collaborations

Ollivier's collaborative efforts have also exemplified his commitment to innovation. He has worked alongside colleagues like Andre Buzas and Jean-Yves Merour, enhancing the scope and reach of his research through teamwork and shared expertise.

Conclusion

In summary, Roland Ollivier is a trailblazer in the development of novel antihistaminic derivatives. His three patents reflect a dedication to enhancing therapeutic options for patients, and his collaborations further showcase the importance of teamwork in driving innovation within the pharmaceutical industry. As he continues to explore new frontiers in medicinal chemistry, Ollivier's contributions remain invaluable to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…